| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics, Inc. | Director | Stock Options | 25,000 | 28 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123040283-nakanishi-xin-2023-06-28 | Oncternal Therapeutics, Inc. | 28 Jun 2023 | 1 | $0 | 4 | Director | 30 Jun 2023, 16:00 |
| /report/000120919122038034-nakanishi-xin-2022-06-16 | Oncternal Therapeutics, Inc. | 16 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 18:00 |
| /report/000120919121036314-nakanishi-xin-2021-05-25 | Oncternal Therapeutics, Inc. | 25 May 2021 | 1 | $0 | 4 | Director | 27 May 2021, 18:06 |